Sort
21,281 grants matching “influenza”
Combined adjuvant approaches for enhancement of SARS-CoV-2 vaccine efficacy
$725,288Pamela Tinmoi Wong · University Of Michigan At Ann Arbor · R01 · FY2023 · AI
Genetic Markers of Long-Term Mumps Vaccine Immunity
$725,120Richard B Kennedy · Mayo Clinic Rochester · R01 · FY2018 · AI
Case-Cohort Study of Cancers in Excess in Poultry Workers
$724,987Eric S. Johnson · Univ Of Arkansas For Med Scis · R01 · FY2011 · OH
Case-Cohort Study of Cancers in Excess in Poultry Workers
$724,920Eric S. Johnson · Univ Of Arkansas For Med Scis · R01 · FY2013 · OH
Case-Cohort Study of Cancers in Excess in Poultry Workers
$724,909Eric S. Johnson · Univ Of Arkansas For Med Scis · R01 · FY2014 · OH
Effects of aging on primary and secondary vaccine responses in a 15-year longitudinal cohort
$724,766Scott Dexter Boyd · Stanford University · R01 · FY2019 · AI
Microneedle-based immunization against pandemic influenza
$724,647Mark R Prausnitz · Georgia Institute Of Technology · R01 · FY2007 · EB
HMGB1-mediated host response to chronic bacterial infection
$724,279Steven D Goodman · Research Inst Nationwide Children'S Hosp · R01 · FY2021 · AI
Neisserial porins and antigen presenting cells
$724,093Lee Mark Wetzler · Boston Medical Center · R01 · FY2016 · AI
Case-Cohort Study of Cancers in Excess in Poultry Workers
$724,063Eric S. Johnson · Univ Of Arkansas For Med Scis · R01 · FY2015 · OH
Improving predictive capacity of models for universal influenza vaccine development
$723,996Richard John Webby · St. Jude Children'S Research Hospital · R01 · FY2020 · AI
Vervet Research Colony as a Biomedical Resource
$723,833Matthew Jorgensen · Wake Forest University Health Sciences · P40 · FY2023 · OD
Component for Institution # 19-01414
$723,833Matthew Jorgensen · Wake Forest University Health Sciences · P40 · FY2024 · OD
Component for Institution # 19-01414
$723,833Matthew Jorgensen · Wake Forest University Health Sciences · P40 · FY2021 · OD
Vervet Research Colony as a Biomedical Resource
$723,833Matthew Jorgensen · Wake Forest University Health Sciences · P40 · FY2022 · OD
Component for Institution # 19-01414
$723,833Matthew Jorgensen · Wake Forest University Health Sciences · P40 · FY2023 · OD
Vervet Research Colony as a Biomedical Resource
$723,833Matthew Jorgensen · Wake Forest University Health Sciences · P40 · FY2024 · OD
Vervet Research Colony as a Biomedical Resource
$723,833Matthew Jorgensen · Wake Forest University Health Sciences · P40 · FY2020 · OD
Vervet Research Colony as a Biomedical Resource
$723,833Matthew Jorgensen · Wake Forest University Health Sciences · P40 · FY2021 · OD
Component for Institution # 19-01414
$723,833Matthew Jorgensen · Wake Forest University Health Sciences · P40 · FY2020 · OD
Mitochondrial maladaptive response of the lung epithelium to elevated CO2 levels
$723,736Jacob I Sznajder · Northwestern University At Chicago · R01 · FY2024 · HL
Mitochondrial maladaptive response of the lung epithelium to elevated CO2 levels
$723,736Jacob I Sznajder · Northwestern University At Chicago · R01 · FY2025 · HL
De Novo Design of Minibinder Antagonists for COVID-19 and Future Pandemics
$723,634David Baker · University Of Washington · R01 · FY2021 · AI
Longitudinal Impact of Respiratory Viruses on Bronchiolitis Obliterans Syndrome in Allogeneic Hematopoietic Cell Transplant Recipients
$723,553Guang-Shing Cheng · Fred Hutchinson Cancer Center · R01 · FY2022 · HL
mRNA-encoded Cas13 as a pan-respiratory antiviral
$723,501Philip J Santangelo · Emory University · R01 · FY2023 · AI